GLP1 - Using This Medicine Effectively for Menopausal Weight Gain

Like anything that comes to the beauty and wellbeing market, we are often led to believe that it it the latest miracle cure for whatever is trending at the time.

There is absolutely no doubt that GLP1 (aka Ozempic & Mounjaro) is being sold as exactly that!

It is an incredible medicine that can be prescribed off licence to help men and women control their apetite and lose weight. (It's actual on licence use is for people who are Diabetic to help control insulin and apatite)

What GLP‑1 Medicines Are

GLP‑1 receptor agonists (and the newer dual GIP/GLP‑1 drugs) are injectable or oral medicines originally developed for type 2 diabetes and now widely used for medical weight management. They mimic gut hormones that signal fullness, slow stomach emptying, increase insulin after meals, and reduce glucagon, so people feel satisfied on fewer calories and see better glucose control.

Menopause, Weight Gain and How GLP‑1 Helps

During peri‑ and post‑menopause, falling oestrogen, reduced muscle mass, and lower insulin sensitivity make weight gain especially around the stomach much more likely.

Studies and reviews suggest GLP‑1 medicines can help menopausal and postmenopausal women lose weight, reduce central (abdominal) fat, and improve metabolic markers like blood pressure, cholesterol and insulin resistance when combined with lifestyle changes. Many women also report less “food noise” and emotional eating, which can make sticking to a lower‑calorie, higher‑protein way of eating more sustainable during menopause. Early data hints that some women may see improvements in vasomotor symptoms (like hot flushes), but evidence is still limited and GLP‑1s do not replace hormone replacement therapy for core menopause symptoms.

But it is no silver bullet!! - This medicine needs careful consideration and monitoring. The rise of online chemists selling the drug without adequate support for the user is resulting in more and more women becoming at risk of osteoporosis due to radical loss of muscle mass.

In depth studies have revealed that muscle AND bones work in harmony. When the muscle is stimulated there are signals sent to bone tissue to encourage the creation of density withing the bone structure. The harder the muscle works, the tougher the bones become.

When muscle mass is depleted (a condition often called sarcopenia), bones undergo a process of accelerated weakening and loss of density. Because muscle and bone are deeply interconnected—working together as a functional unit—the loss of mechanical strain from muscle contraction signals the body to break down bone tissue, leading to a state of increased fragility.

• Accelerated Bone Loss (Osteopenia/Osteoporosis): As muscles shrink, they produce less force. According to Wolff's Law, which states that bones adapt to the loads under which they are placed, this reduction in mechanical load causes bone remodeling to become unbalanced. Bone resorption (breakdown) exceeds bone formation, leading to decreased bone mineral density.

• Increased Bone Brittleness: The bones become more fragile, thinner, and less dense, particularly at the hip and spine.

• Structural Deterioration: The inner structure of the bone (trabecular bone) becomes thinner, and the outer layer (cortical bone) becomes more porous.

• Higher Risk of Fractures and Falls: The combination of weakened bones and decreased muscle strength significantly increases the likelihood of falls, which, when coupled with decreased bone strength, leads to a higher risk of fractures (fragility fractures).

• Loss of Structural Support: The decrease in muscle mass can cause a loss in overall stature, often resulting in a hunched posture (kyphosis) and a narrowing of bones

Why Strength Training Is Essential on GLP‑1

GLP‑1 medicines often lead to a substantial drop in overall calorie intake, which can incidentally lower protein intake too. Without enough protein and regular resistance training, a significant proportion of the weight you lose up to around 30–40% in some reports and can come from lean mass rather than fat.

Losing muscle during midlife is the opposite of what you want, because muscle helps to:

• Maintain resting metabolic rate, supporting long‑term weight maintenance.

• Improve insulin sensitivity and blood sugar control, which are often under strain after menopause.

• Protect joints, bones and balance, lowering the risk of falls and fractures as you age.

A simple, realistic strength‑training framework while on GLP‑1 might include:

• 2–3 sessions per week focusing on major movement patterns: squat, hinge (e.g. deadlift or hip hinge), push, pull, and carry.

• 2–4 sets of 8–12 controlled reps per exercise, with weights that feel challenging by the last few reps but still allow good form.

• Prioritising protein at each meal (for most midlife women, often 20–30 g per meal, adjusted by a clinician or dietitian) to support muscle repair and retention.

Cardio still matters, for heart health, fitness, and mood but for women on GLP‑1s, resistance work is a non‑negotiable partner to protect muscle and make fat loss truly sustainable.

Who GLP‑1 Weight‑Loss Medicines Are Not Suitable For

These medicines are prescription‑only and must be started and monitored by a clinician who understands your medical history. Here at NU-U LAB our medical weighloss clinic is overseen by 2 medically trained nurses and prescibers. We offer a comprehensive support option for clients wanting to remove the unwanted weight gain (PROVIDING YOUR BMI IS IN THE HIGH OVERWEIGHT TO OBESE RANGE) And further support can be given from our local female health and fitness expert.

Key groups where GLP‑1 (and GIP/GLP‑1) therapies are usually avoided or need extreme caution include:

• Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2) – this is an absolute contraindication due to thyroid tumour risk signals in animal studies.

• Previous serious hypersensitivity or allergic reaction to a GLP‑1 medicine.

• Current or planned pregnancy – GLP‑1s are not recommended as they have shown adverse foetal effects in animal studies.

• Breastfeeding – there is very limited safety data, so most guidelines advise against or recommend great caution.

• Significant gastroparesis or severe gastrointestinal disease (e.g. some inflammatory bowel conditions), because GLP‑1s slow stomach emptying and can worsen symptoms.

• History of pancreatitis, active gallbladder disease, or significant diabetic retinopathy, where specialist review is needed before prescribing.[3][6]

Menopause itself is not a contraindication, but women with complex cardiovascular disease, multiple medications, or previous eating disorders should have an individual risk–benefit discussion with a menopause‑literate clinician before starting treatment. If you choose NU-U LAB to start your weightloss journey, your complete medical history is taken into consideration and you are monitored monthly.

Putting It All Together for Midlife Women

For many women, the most effective approach to menopausal weight gain is a combination of medical therapy (where appropriate), nutrition, movement, sleep, and stress support, not a single “magic jab.”

If we decide GLP‑1 therapy is right for you, pairing it with structured strength training and adequate protein can help you lose more fat, preserve muscle, and feel stronger and more resilient through midlife and beyond.

To book your one to one, face to face consultation (I do not offer face time appointments for this) Please email me directly at the clinic. The consultation and menopause support session for 1 hour is £40 and the medicine is prescribed additionally.